Physicians Realty Trust (NYSE:DOC) had its target price lowered by investment analysts at Morgan Stanley from $18.00 to $14.00 in a research report issued to clients and investors on Thursday, BenzingaRatingsTable reports. The brokerage currently has an “equal weight” rating on the real estate investment trust’s stock. Morgan Stanley’s price objective points to a potential downside of 0.07% from the stock’s previous close.

Several other equities research analysts have also recently issued reports on DOC. Capital One Financial raised shares of Physicians Realty Trust from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $18.50 to $22.00 in a research report on Thursday, February 27th. B. Riley raised their target price on shares of Physicians Realty Trust from $20.00 to $22.00 and gave the stock a “buy” rating in a research report on Thursday, February 27th. BTIG Research cut shares of Physicians Realty Trust from a “buy” rating to a “neutral” rating in a research report on Monday, March 16th. Raymond James raised their target price on shares of Physicians Realty Trust from $20.00 to $22.00 and gave the stock an “outperform” rating in a research report on Thursday, March 12th. Finally, KeyCorp raised their target price on shares of Physicians Realty Trust from $19.00 to $20.00 and gave the stock an “overweight” rating in a research report on Thursday, January 16th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $20.00.

Shares of NYSE DOC traded up $0.30 during midday trading on Thursday, reaching $14.01. 667,593 shares of the stock were exchanged, compared to its average volume of 3,930,094. The company has a market capitalization of $2.67 billion, a P/E ratio of 35.03, a P/E/G ratio of 4.99 and a beta of 0.51. Physicians Realty Trust has a 52-week low of $11.01 and a 52-week high of $20.78. The company has a current ratio of 2.15, a quick ratio of 2.15 and a debt-to-equity ratio of 0.68. The stock has a 50 day moving average price of $18.46 and a 200-day moving average price of $18.42.

Physicians Realty Trust (NYSE:DOC) last issued its quarterly earnings results on Wednesday, February 26th. The real estate investment trust reported $0.22 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.05). The firm had revenue of $107.42 million for the quarter, compared to analysts’ expectations of $109.57 million. Physicians Realty Trust had a return on equity of 3.04% and a net margin of 17.94%. The business’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.27 earnings per share. On average, analysts forecast that Physicians Realty Trust will post 1.08 earnings per share for the current year.

In related news, insider John W. Lucey purchased 3,145 shares of the company’s stock in a transaction that occurred on Friday, March 13th. The stock was acquired at an average price of $15.97 per share, for a total transaction of $50,225.65. Following the completion of the purchase, the insider now owns 92,699 shares in the company, valued at $1,480,403.03. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Stanton D. Anderson sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $20.09, for a total transaction of $100,450.00. Following the sale, the director now owns 37,710 shares of the company’s stock, valued at approximately $757,593.90. The disclosure for this sale can be found here. Insiders own 0.62% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in DOC. Norges Bank bought a new stake in Physicians Realty Trust during the fourth quarter valued at $64,219,000. Nuveen Asset Management LLC increased its stake in Physicians Realty Trust by 141.6% during the fourth quarter. Nuveen Asset Management LLC now owns 4,769,218 shares of the real estate investment trust’s stock valued at $90,329,000 after purchasing an additional 2,795,461 shares during the last quarter. Heitman Real Estate Securities LLC bought a new position in shares of Physicians Realty Trust during the fourth quarter worth about $43,829,000. Bank of New York Mellon Corp grew its position in shares of Physicians Realty Trust by 36.4% during the fourth quarter. Bank of New York Mellon Corp now owns 5,707,344 shares of the real estate investment trust’s stock worth $108,098,000 after acquiring an additional 1,521,610 shares during the last quarter. Finally, Raymond James & Associates grew its position in shares of Physicians Realty Trust by 494.8% during the fourth quarter. Raymond James & Associates now owns 1,241,867 shares of the real estate investment trust’s stock worth $23,521,000 after acquiring an additional 1,033,070 shares during the last quarter. Hedge funds and other institutional investors own 86.88% of the company’s stock.

Physicians Realty Trust Company Profile

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare.

Featured Article: How Do Tariffs Affect Trade Balances?

Analyst Recommendations for Physicians Realty Trust (NYSE:DOC)

Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.